Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions

Area of Science:

• Pharmaceutical Science
• Drug Delivery Systems

Background:

• Many new drug candidates exhibit poor aqueous solubility, hindering oral bioavailability.
• Amorphous solid dispersions (ASDs) are a key strategy to overcome these limitations.

Purpose of the Study:

• To review recent advancements in solubility and bioavailability enhancement using ASDs.
• To discuss the mechanisms, challenges, and future directions in ASD technology.

Main Methods:

• Literature review focusing on amorphous solid dispersions for drug solubility enhancement.
• Exploration of process analytical technology (PAT) and computational tools in ASD development.
• Analysis of continuous manufacturing applications for ASDs.

Main Results:

• ASDs significantly improve dissolution and oral bioavailability of poorly soluble drugs.
• Molecular modeling and data science accelerate the prediction of drug-carrier interactions.
• Continuous manufacturing offers efficient and scalable production of ASDs.

Conclusions:

• ASDs represent a promising approach for developing poorly soluble drugs.
• Advancements in PAT, AI, and computational tools are crucial for future ASD research and development.
• Clinical studies and market introduction of ASDs are increasing, highlighting their therapeutic potential.